Kenneth G. Mertz II
@Emerald Mutual Fund Advisers Trust
Latest period2024 - Q3ReportedManaged Assets$1.925BTotal holdings225
Assets growth rate0.84%Assets growth rate (2-Q avg)0.12%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Emerald Mutual Fund Advisers Trust's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 225 positions.
Assets under management
The assets under management (AUM) of Emerald Mutual Fund Advisers Trust over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.925B in assets, with a quarterly growth rate of 0.84% and a 2-quarter average growth rate of 0.12%. The portfolio is managed by Kenneth G. Mertz II, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BBIOBridgebio Pharma Inc
| 1% | $19.129M 751,355 shares@ $25.46 avg price | Increased 50.8% |
VITLVital Farms Inc
| 0.97% | $18.646M 531,676 shares@ $35.07 avg price | Increased 93.92% |
OLLIOllie's Bargain Outlet Holdings
| 0.97% | $18.58M 191,153 shares@ $97.21 avg price | Increased 7.05% |
LITELumentum Holdings Inc
| 0.93% | $17.831M 281,331 shares@ $63.39 avg price | Increased 19.35% |
RMBSRambus Inc
| 0.93% | $17.813M 421,917 shares@ $42.23 avg price | Increased 37.57% |
WVEWave Life Sciences Ltd
| 0.91% | $17.412M 2.123M shares@ $8.2 avg price | Increased 16.62% |
IDCCInterdigital Inc Pa Com
| 0.88% | $16.871M 119,122 shares@ $141.64 avg price | Increased 23.49% |
NSSCNapco Security
| 0.88% | $16.751M 414,013 shares@ $40.47 avg price | Increased 3.52% |
RXORxo Inc
| 0.87% | $16.623M 593,663 shares@ $28.0 avg price | Increased 66.75% |
TVTXTravere Therapeutics Inc
| 0.87% | $16.588M 1.186M shares@ $14.0 avg price | Increased 25.97% |